Primary Cells or Cell Lines | RT-PCR | Bisulfite Sequencing | ChIP Assay |
---|---|---|---|
ES Cells | Fig. 1 | Fig. 4 | Fig. 3 |
Sertoli cells (TM4) | Fig. 1 | Fig. 4 | Fig. 3 |
Mononucleocytes (MNC) | Fig. 1 | Fig. 4 | Fig. 3 |
CT26 (colon cancer) | Fig. 1 | Fig. 4 | Fig. 3 |
MC38 (colon cancer) | Fig. 1 | Fig. 4 | Fig. 3 |
4T1 (mammary cancer) | Fig. 1 | Fig. 4 | AF. 1 |
EMT6 (mammary cancer) | Fig. 1 | Fig. 4 | Fig. 3; Fig. 5 |
P815 cells (mastocytoma) | Fig. 4 | AF. 2 | Fig. 5; AF. 1 |
EMT6 & P815 cells treated with epigenetic drugs | Fig. 4 | n.d. | Fig. 5 |
F9 (embryonic carcinoma) | Fig. 1; Fig. 5 | n.d. | Fig. 5 |
MOSEC (ovarian cancer) | Fig. 1; Fig. 6 | Fig. 4 | Fig. 3 |
MOSEC SP | Fig. 6 | n.d. | Fig. 6 |